pd 98059 has been researched along with sodium tungstate(vi) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baqué, S; Barberà, A; Caron, M; Domínguez, JE; Gomis, R; Guinovart, JJ; Mercurio, C; Muñoz, MC; Perona, R; Sanchez-Perez, I; Zafra, D | 1 |
| Avila, J; Corominola, H; Domínguez, J; Gómez-Ramos, A; Gomis, R; Guinovart, JJ; Zafra, D | 1 |
2 other study(ies) available for pd 98059 and sodium tungstate(vi)
| Article | Year |
|---|---|
The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glucose; Glycogen; Hepatocytes; Humans; Hypoglycemic Agents; Immunoblotting; Insulin; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotyrosine; Rats; Rats, Wistar; Receptor, Insulin; Time Factors; Transfection; Tungsten Compounds | 2003 |
Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation.
Topics: Animals; Blotting, Western; Brain; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Enzyme Reactivators; Flavonoids; Glycogen Synthase Kinase 3; Humans; Insulin; Lithium; Male; Mitogen-Activated Protein Kinase 3; Models, Molecular; Neuroblastoma; Phosphorylation; Rats; Serine; tau Proteins; Time Factors; Tungsten Compounds | 2006 |